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Summary
Background:  Southeast  Asia  remains  a  critical  region  for  the  emergence  of  novel
and/or  zoonotic  inﬂuenza,  underscoring  the  importance  of  extensive  sampling  in
rural  areas  where  early  transmission  is  most  likely  to  occur.
Methods:  In  2008,  800  adult  participants  from  eight  sites  were  enrolled  in  a  prospec-
tive  population-based  study  of  avian  inﬂuenza  (AI)  virus  transmission  where  highly
pathogenic  avian  inﬂuenza  (HPAI)  H5N1  virus  had  been  reported  in  humans  and  poul-
try  from  2006  to  2008.  From  their  enrollment  sera  and  questionnaires,  we  report  riskCohort studies factor  ﬁndings  for  serologic  evidence  of  previous  infection  with  18  AI  virus  strains.
Results:  Serologic  assays  revealed  no  evidence  of  previous  infection  with  13  dif-
ferent  low-pathogenic  AI  viruses  or  with  HPAI  avian-like  A/Cambodia/R0404050/
2007(H5N1).  However,  21  participants  had  elevated  antibodies  against  avian-like
A/Hong  Kong/1073/1999(H9N2),  validated  with  a monoclonal  antibody  blocking
ELISA  assay  speciﬁc  for  avian  H9.
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Conclusions:  Although  cross-reaction  from  antibodies  against  human  inﬂuenza  viruses
cannot  be  completely  excluded,  the  study  data  suggest  that  a  number  of  participants
were  previously  infected  with  the  avian-like  A/Hong  Kong/1073/1999(H9N2)  virus,
likely  due  to  as  yet  unidentiﬁed  environmental  exposures.  Prospective  data  from  this
cohort  will  help  us  better  understand  the  serology  of  zoonotic  inﬂuenza  infection  in
a  rural  cohort  in  SE  Asia.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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resulted  in  one  adult  being  selected  for  study
enrollment. All  selected  participants  were  then©  2013  King  Saud  Bin  Ab
Ltd.  All  rights  reserved.
Introduction
Describing  the  epidemiology  of  and  controlling
highly pathogenic  avian  inﬂuenza  (HPAI)  have  been
major challenges  for  many  countries  in  Asia.  In
Cambodia,  HPAI  H5N1  virus  control  has  been  partic-
ularly difﬁcult,  as  household  ownership  of  backyard
poultry  is  widespread,  movement  of  birds  is com-
mon, poultry-handling  behaviors  are  difﬁcult  to
modify,  and  considerable  evidence  of  human  HPAI
H5N1 virus  exposure  exists  [1—9].
Detection  of  HPAI  H5N1  in  Cambodian  poultry
ﬁrst occurred  in  January  2004  and  has  continued
[1,10,11], with  the  most  recent  detection  in  June
2012, as  reported  by  the  World  Organization  for
Animal Health  (OIE).  Human  cases  have  been  spo-
radic. As  of  August  2012,  Cambodia  has  reported
21 human  HPAI  H5N1  infections  to  the  World  Health
Organization,  with  19  fatalities.
As with  much  of  Asia,  inﬂuenza  surveillance
in Cambodia  chieﬂy  involves  assessing  ill  patients
who seek  medical  attention  at  large  urban  medi-
cal facilities  [12].  Vong  et  al.  [9]  have  suggested
that clinic-based  surveillance  systems  may  over-
look mild  or  sub-clinical  HPAI  H5N1  virus  infections
among  persons  residing  in  rural  areas  with  close
contact  with  sick  or  dead  poultry  suspected  to  be
linked to  HPAI  H5N1  virus.  Our  report  documents
the establishment  of  a  prospective  cohort  study  of
800 rural  Khmer  adults  in  central  Cambodia  with
the primary  objective  of  describing  risk  factors  for
zoonotic inﬂuenza  infection.
Materials and methods
Study location
Six  months  prior  to  enrollment,  our  Cambodian  ﬁeld
staff contacted  village  leaders  and  local  Ministry  of
Health/Ministry  of  Agriculture  ofﬁcers  to  determine
the  best  rural  villages  in  which  to  conduct  enroll-
ment  for  a  cohort  study.  Considerations  included
early  reports  of  HPAI  H5N1  detection,  proximity  to
the central  reference  laboratory  in  Phnom  Penh,
Cambodia,  human  population  size  and  density,  total
e
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tumber  of  homes,  number  of  homes  raising  poultry
nd swine,  and  the  variety  of  poultry.
Based on  pre-enrollment  assessments,  Kampong
ham Province  was  selected  as  the  study  area
Fig. 1).  Kampong  Cham  has  a land  area  of  approx-
mately  9000  km2, the  largest  human  population  of
ny province  in  Cambodia  (nearly  1.7  million)  and
ad an  estimated  1  million  chickens  and  260,000
ucks at  the  time  of  the  study  (personal  commu-
ication Kampong  Cham  Agriculture  Department).
ithin the  Kampong  Cham  province,  four  districts
Batheay,  Cheung  Prey,  Tboung  Khmum,  and  Pon-
ea Kraek)  were  identiﬁed  as  having  high  poultry
ounts. Within  these  districts,  eight  sites  were
elected  as  cohort  enrollment  ﬁeld  sites  (Fig.  1).
nrollment
dults  who  lived  in  the  study  villages  were  recruited
nd trained  as  staff  ﬁeld  workers  with  the  respon-
ibility to  conduct  study  enrollments  and  follow-up
ncounters.  First,  houses  in  the  study  villages  were
apped and  sequentially  numbered.  Then,  using
 systematic  sampling  approach  with  a  random-
umber generated  start,  staff  ﬁeld  workers  met
ith adults  ≥20  years  of  age  in  each  selected  house-
old to  explain  the  study.  Study  inclusion  required
hat potential  enrollees  were  ≥20  years  of  age,
esided  in  the  household  for  20  or  more  days  each
onth  and  had  no  known  immunosuppressive  con-
itions. In  addition,  potential  participants  were
nformed  of  the  prospective  nature  of  the  study,
hich  involved  an  annual  revisit  to  collect  a  blood
pecimen,  weekly  active  surveillance  for  inﬂuenza-
ike illness  (ILI),  and  an  additional  ‘family’  study
o assess  the  secondary  spread  of  inﬂuenza  within
 household  if  a  conﬁrmed  inﬂuenza  virus  infection
ccurred. Willing  and  eligible  potential  participants
ere  assigned  a  randomly  generated  selection  num-
er. A  random  draw  of  household  selection  numbersnrolled  using  informed  consent.  Study  partici-
ants were  interviewed  by  staff  ﬁeld  workers,
ho completed  enrollment  forms,  collected  sera,
rained villagers  to  use  digital  thermometers,  and
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Figure  1  Map  of  key  study  sites  in  Cambodia.  0  =  NAMRU2/NIPH  laboratory,  1  =  Kampong  Cham  provincial  hospital,
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p =  Tangil  and  Tang  Krang  villages,  3  =  Boeng  Chrouy  vill
illage,  7  =  Trapeang  Chhuk  village,  8  =  Chong  Angkrang  vi
rovided  instructions  about  how  to  contact  ﬁeld
tudy personnel  during  a  suspected  ILI  event.  For
his cohort  study,  ILI  was  deﬁned  as  an  acute  onset
f a  respiratory  illness  with  a  measured  tempera-
ure ≥38 ◦C  (100.5 ◦F)  and  a  sore  throat  or  cough
or four  or  more  hours.  Poultry  and  swine  exposure
as deﬁned  as  having  at  least  30  min  of  continuous
xposure within  1  m  to  live  poultry  or  swine.  Sub-
ects  were  enrolled  from  April  to  October  in  2008,
nd in  this  study,  we  report  only  serological  analy-
es from  these  sera.  Final  serological  analyses  were
erformed  in  late  2010.aboratory methods
hole  blood  specimens  were  transported  at
0—15 ◦C  to  the  NAMRU-2/NIPH  laboratory  in  Phnom
H
T
i
v 4  =  Roveang  village,  5  =  Svay  Prey  village,  6  =  Doun  Tao
 and  9  =  La  Ork  village.
enh  between  12  and  24  h after  collection.  After
eparation,  collected  sera  were  preserved  at
80 ◦C  until  transported  on  dry  ice  to  our  inﬂuenza
aboratory at  the  University  of  Iowa  for  testing.
A hemagglutination  inhibition  (HI)  assay  was
sed to  examine  human  sera  for  antibodies  against
uman  and  swine  inﬂuenza  viruses,  and  a microneu-
ralization  (MN)  assay  was  performed  to  examine
uman  sera  for  antibodies  against  viruses  of  avian
rigin.  Avian  inﬂuenza  virus  strains  were  selected
y H  type  for  their  best  geographic  and  temporal
roximity to  the  population  (Table  1).emagglutination  inhibition  assay
he  HI  assay  was  conducted  against  two  swine
nﬂuenza viruses  (SIVs),  ﬁve  human  inﬂuenza
iruses, and  the  2009  pandemic  H1N1  inﬂuenza  A
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Table  1  Viruses  used  in  serological  studies.  Unless  otherwise  indicated,  serologic  study  was  performed  using  the
microneutralization  technique.
Avian  viruses  Swine  viruses
A/Duck/Alberta/35/76(H1N1)  A/Swine/Wisconsin/238/97(H1N1)a
A/Env/Hong  Kong/MP43156/2005(H2N2)  A/Swine/Minnesota/593/99(H3N2)a
A/Duck/Czechoslovakia/56(H4N6)
A/Migratory  duck/Hong  Kong/MPS180/2003(H4N6)  Human  viruses
A/Chucker/Minnesota/14591-7/98(H5N2) A/New  Caledonia/20/99(H1N1)a
A/Teal/Hong  Kong/w312/97(H6N1) A/Brisbane/59/2007(H1N1)a
A/Turkey/Massachusetts/65(H6N2) A/Panama/2007/99(H3N2)a
A/Turkey/Virginia/4529/2002(H7N2) A/Brisbane/10/2007(H3N2)a
A/WF/Hong  Kong/Mpb127/2005(H7N7) A/Cambodia/R0404050/2007(H5N1)b c
A/Turkey/Ontario/6118/68(H8N4) A/Hong  Kong/1073/1999(H9N2)b
A/Migratory  duck/Hong  Kong/MP2553/04(H8N4) A/Pandemic/Mexico/4108/2009(H1N1)a
A/Turkey/Minnesota/38391(H9N2) A/Japan/305/1957(H2N2)d
A/Migratory  duck/Hong  Kong/MPD268/2007(H10N4)
A/Chicken/Germany/49(H10N7)
A/Duck/Memphis/546/74(H11N9)
A/Duck/Alberta/60/76(H12N5)
a Virus studied with hemagglutination inhibition assay.
b Virus of avian origin.
c Highly pathogenic virus.
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virus  (Table  1).  The  inﬂuenza  virus  strains  were
grown  in  embryonated  chicken  eggs.  Sera  were
pre-treated with  receptor-destroying  enzyme  and
hemadsorbed  with  guinea  pig  or  turkey  erythro-
cytes. Titer  results  are  reported  as  the  reciprocal
of the  highest  dilution  of  serum  that  inhibited  virus-
induced hemagglutination  of  a  0.65%  (guinea  pig)  or
0.50% (turkey)  solution  of  erythrocytes.
Microneutralization  assay
A MN  assay  adapted  from  Rowe  [13]  was  used  to
detect antibodies  to  a  large  panel  of  avian  and
avian-like viruses  (Table  1).  These  viruses  were
grown  in  embryonic  chicken  eggs.  As  seropreva-
lence was  expected  to  be  low,  sera  were  ﬁrst
screened at  a  dilution  of  1:10.  Positive  specimens
were then  titered  out  in  duplicate  by  examining
2-fold serial  dilutions  from  1:10  to  1:1280  in  virus
diluent  [85.8%  minimum  essential  medium  (Invitro-
gen, Carlsbad,  CA),  0.56%  BSA,  25  mM  HEPES  buffer
(Invitrogen),  100  mg/L  streptomycin  (Invitrogen),
and 100,000  units/L  penicillin  (Invitrogen)].  Virus
neutralization  was  performed  by  adding  100  TCID50
of  virus  to  the  sera.  The  Reed  Muench  method
was used  to  determine  the  TCID50/100  L  [14].
MDCK  cells  in  log-phase  growth  were  adjusted
to 2.0  × 105 cells/mL  with  dilulent.  One  hundred
microliters of  cells  were  added  to  each  well,  and
the plate  was  incubated  at  37 ◦C  with  5%  CO2 for
24 h.  Plates  were  washed  twice  with  PBS,  ﬁxed
with cold  80%  acetone,  and  incubated  at  room
1
d
t
wemperature  for  10  min.  The  ELISA  endpoint  titer
as expressed  as  the  reciprocal  of  the  highest  dilu-
ion of  serum  with  an  optical  density  (OD)  less
han X,  where  X  = [(average  OD  of  virus  control
ells) +  (average  OD  of  cell  control  wells)]/2.  Test
ells with  an  OD  >  2  times  the  cell  control  OD  mean
ere considered  positive  for  virus  growth.  The  back
iter was  run  in  duplicate  and  was  only  accepted
hen both  replicates  had  matching  results.
locking  ELISA
 monoclonal  antibody  assay  was  used  in  a  block-
ng ELISA  format  to  validate  the  MN  results  against
/Hong  Kong/1073/1999(H9N2)  virus.  In  the  block-
ng ELISA,  A/Guinea  fowl/Hong  Kong/WF10(H9N2)
irus was  used  as  coating  antigen,  and  HRP-
onjugated monoclonal  antibody  3G8  against  HA
f avian  H9  inﬂuenza  virus  (developed  by coau-
hor Hongxia  Shao)  was  selected  as  the  detection
ntibody. A/Guinea  fowl/Hong  Kong/WF10(H9N2)
irus (diluted  in  carbonate/bicarbonate  buffer,  pH
.6) was  coated  on  96-well  plates  for  12  h  at  4 ◦C.
fter blocking  the  plates  with  5%  (w/v)  non-fat
ilk in  PBS  for  1 h  at  37 ◦C,  the  samples  were
iluted (1:4)  in  dilution  buffer  (0.5%  BSA  in  PBS)  and
ere added  to  the  wells  (100  L/well).  The  mix-
ure was  incubated  at  37 ◦C  for  1  h.  After  one  wash,
00 L  HRP-conjugated  3G8  (0.1  ng/mL)  diluted  in
ilution buffer  was  added  to  well,  and  the  mix-
ure was  incubated  for  1  h at  37 ◦C.  After  ﬁve
ashes, the  development  was  performed  using  the
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MB  substrate  system  (KPL,  Gaithersburg,  Mary-
and, USA)  for  15  min.  The  ratio  of  the  OD50 value  of
he sample  wells  (S)  to  that  of  the  negative  control
ells  (N)  was  calculated,  and  S/N  values  less  than
.5 were  considered  as  positive  in  the  ELISA.
tatistical methods
uestionnaire  data  were  manually  entered  twice
n a  relational  database  (Microsoft  Inc.,  Redmond,
A, USA)  and  veriﬁed  for  data  entry  problems
nd questionnaire  administration  inconsistencies
ith structured  query  language.  Questionnaire  data
nd laboratory  data  were  later  merged,  using
nique study  subject  numbers,  into  a  master
ataset.
Our primary  study  outcome  was  serological
vidence of  previous  zoonotic  inﬂuenza  infec-
ion determined  by  the  MN  assay.  Due  to  a  low
revalence of  elevated  antibodies  against  the  var-
ous avian  inﬂuenza  viruses  and  our  inability  to
etermine  when  such  an  infection  might  have
ccurred, we  chose  a  low  threshold  of  antibody
iter (≥1:10)  as  evidence  of  previous  infection  with
n avian  inﬂuenza  strain.  Because  we  know  that
ross-reactions  from  previous  infection  with  human
nﬂuenza  viruses  might  confound  avian  inﬂuenza
irus serology,  we  sought  to  control  this  confound-
ng by  adding  human  and  swine  inﬂuenza  virus
eactivity results  as  covariates  to  the  multivari-
te models  when  the  bivariate  analyses  suggested
hey  were  important  outcome  predictors.  As  we
ave reported  previously  [15,16],  we  accepted  a HI
iter ≥1:40  as  evidence  of  previous  human  or  swine
nﬂuenza  virus  infection  or  vaccination.  The  Kappa
est and  the  Spearman  rank  correlation  test  were
sed to  evaluate  assay  agreement.
Initially,  we  examined  risk  factors  for  bivari-
te associations  with  MN  assay  results  using  binary
ogistic  regression  and  proportional  odds  model-
ng [17].  The  risk  factors  included:  gender,  age
roup, inﬂuenza  vaccination  history,  seropositivity
or human  inﬂuenza  viruses,  indoor  water,  poultry
xposure,  average  animal  contact  per  year,  out-
reaks,  heart  disease,  respiratory  disease,  ILI  in  the
amily or  at  work,  and  use  of  personal  protective
quipment.  An  exact  conditional  method  was  used
or sparse  data,  and  the  score  test  was  used  to  eval-
ate the  proportional  odds  assumption.  Covariates
ith  p  values  <0.25  were  considered  for  inclusion
n multivariate  models.  Final  multivariate  models
ere designed  using  manual  backwards  elimination
nd  included  covariates  with  p  values  <0.05.  Anal-
ses were  performed  using  SAS  v9.2  (SAS  Institute,
nc., Cary,  NC,  USA).
a
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H
s73
esults
rom  April  to  October  2008,  ﬁeld  staff  enrolled
 total  of  800  participants,  100  from  each  of
ight study  sites  (Fig.  1),  with  an  overall  house-
old refusal  rate  of  7.5%.  The  participants  had  a
edian age  of  39.6  years,  were  more  likely  to
e female  (66.6%),  and  had  no  access  to  indoor
lumbing (99.7%).  None  of  the  study  enrollees
eported any  history  of  human  inﬂuenza  vac-
ine. Most  participants  reported,  at  baseline,
o taking  medication  during  the  past  30  days
59.5%), and  over  three-quarters  reported  hav-
ng had  a respiratory  illness  during  the  last  12
onths  (75.1%).  A  considerable  percentage  (21.0%)
eported  that  they  had  a history  of  heart  disease,
ypertension, or  stroke,  although  veriﬁcation  of
hese conditions  was  not  conducted.  Poultry  and
wine exposure  was  particularly  prevalent  among
he participants  (93.2%  and  78.0%,  respectively)
Table 2).
Enrollee  serological  assays  revealed  no  reac-
ivity against  A/Cambodia/R0404050/2007(H5N1).
owever,  serological  reactivities  against  two  LPAI
iruses were  compelling.  One  hundred  nine  (13.6%)
f the  participants  had  elevated  titers  (≥1:10)
gainst  A/Env/Hong  Kong/MP43156/2005(H2N2);
owever,  all  but  one  (99.1%)  of  these  participants
as born  before  1968  (data  not  shown).  Twenty-one
ubjects had  elevated  MN  titers  (≥1:10)  against
he avian-like  A/Hong  Kong/1073/1999(H9N2)
irus  (Table  3).  In  unadjusted  comparisons,  an
levated titer  for  antibodies  against  this  H9N2
irus was  associated  with  the  male  gender  and
xposure  to  poultry  or  swine,  although  after
ontrolling for  potential  confounders,  these
ssociations were  no  longer  statistically  signif-
cant. Important  covariates  in  the  multivariate
odel included  older  age  (adjusted  OR  =  6.9;
5% CI,  1.0—47.6),  elevated  MN  titer  (≥1:10)
gainst A/Env/Hong  Kong/MP43156/2005(H2N2)
irus  (adjusted  OR  =  5.5;  95%  CI,  1.8—16.4),
levated HI  titer  (≥1:40)  against  the  human
/Brisbane/59/2007(H1N1)  virus  (adjusted
R =  3.8;  95%  CI,  1.4—10.2),  and  elevated  HI
iter (≥1:40)  against  the  human  A/Brisbane/10/
007(H3N2)  virus  (adjusted  OR  =  0.3;  95%  CI,
.1—0.9).
As Stephenson  et  al.  [18]  have  reported  that
ross-reacting antibodies  against  H2  might  explain
levated  antibodies  against  avian  H9N2,  especially
mong  those  born  prior  to  1968,  we  examined subset  of  study  sera  (14  H9N2-positive  sam-
les and  28  age  group-  and  gender-matched
9N2-negative  samples)  against  a  H2N2  pandemic
train,  A/Japan/305/1957(H2N2).  Comparisons  of
74  P.J.  Blair  et  al.
Table  2  Risk  factors  for  elevated  antibodies  against  A/Hong  Kong/1073/1999(H9N2),  among  study  participants,
Kampong  Cham  province,  Cambodia,  2008.
Variables  Total  N  Avian-like  A/Hong  Kong/1073/1999(H9N2)
n  (%)  Unadjusted  OR  (95%  CI)  Adjusted  OR  (95%  CI)
Age  (years)
≥60 56 5 (23.8)  20.8  (3.3—223)a,b 6.9  (1.0—48)c
40—59  291 14 (66.7)  10.8  (2.4—99)a,b 5.2  (1.0—27)c
20—39  430 2 (9.5)  Reference Reference
Gender
Male  258  12  (57.1)  2.8  (1.2—6.7)c —
Female  519  9  (42.9)  Reference
Poultry  exposure
No 52  4  (19.0)  3.4  (1.1—10.5)c —
Yes  725  17  (81.0)  Reference
Swine  exposure
No  170  12  (57.1)  2.8  (1.2—6.8)c —
Yes  607  9  (42.9)  Reference
A/Brisbane/59/2007(H1N1)d,e
Positive  132  8  (38.1)  3.1  (1.3—7.7)c 3.8  (1.4—10.2)c
Negative  642  13  (61.9)  Reference  Reference
A/Brisbane/10/2007(H3N2)d,e
Positive  560  10  (47.6)  0.3  (0.1—0.8)a 0.3  (0.1—0.9)c
Negative  213  11  (52.4)  Reference  Reference
A/Env/HK/MP43156/2005(H2N2)e,f
Positive  109  14  (66.7)  13.4  (4.9—40.4)a 5.5  (1.8—16.4)c
Negative  649  7  (33.3)  Reference  Reference
Indoor  water
Yes  2  1  (4.8)  37  (0.5—∞)a,b —
No  775  20  (95.2)  Reference
Developed  a  respiratory  illness  in  the  last  12  months
No  191  8  (38.1)  1.9  (0.8—4.8)a —
Yes  586  13  (61.9)  Reference
Ever  used  tobacco  products
Yes  265  10  (47.6)  1.8  (0.8—4.3)c —
No  512  11  (52.4)  Reference
Chronic  breathing  problemse
No 711  2  (9.5)  1.2  (0.3—5.4)c —
Yes 65 18  (85.7)  Reference
a Binary logistic regression (negative = titer < 1:10, positive = titer ≥ 1:10.
b Exact conditional method used.
c Proportional odds model used.
d Negative = titer < 1:40, positive = titer ≥ 1:40.
t
c
i
N
i
t
we These covariates have missing data.
f Negative = titer < 1:10, positive = titer ≥ 1:10.
antibody  titers  for  these  study  participants  (Table  4)
documented poor  agreement  between  MN  H9N2  and
MN human  H2N2  assays  by  exact  bivariate  or  multi-
variate  logistic  regression  (unadjusted  OR  = 2.2,  95%
CI, 0.5—8.5)  or  by  the  Spearman  correlation  method
(r = 0.16,  95%  CI,  −0.18  to  0.46).  Agreement  was
also poor  for  MN  assays  comparing  avian  H9N2  and
avian H2N2.  However,  there  was  statistically  sig-
niﬁcant agreement  for  those  with  detectable  MN
antibodies  against  human  H2N2  and  avian  H2N2
strains  (adjusted  OR  =  25.3;  95%  CI,  3.7—∞;  and
Spearman  r  =  0.80;  95%  CI,  0.70—0.90).
a
H
w
bThe  reactivity  against  the  avian  H9N2  was  fur-
her examined  by  aggregating  4719  serum  samples
ollected  from  2008  to  2010  from  healthy  adults
n Cambodia,  Thailand,  Mongolia,  Romania,  and
igeria. Of  the  4719  samples,  136  (2.9%)  were  pos-
tive by  MN  and  4583  (97.1%)  were  negative.  From
hese samples,  59  positive  and  61  negative  samples
ere selected  by  random  number  and  examined  in blinded  fashion  with  the  validative  monoclonal
9 blocking  ELISA.  Of  the  120  samples,  59  (49.2%)
ere positive  by  MN,  but  only  30  (25%)  were  positive
y ELISA.  However,  of  the  30  positive  by  ELISA,  27
Human  avian  H9N2  inﬂuenza  infections  
Table  3  Distribution  of  elevated  microneutralization
titers  against  A/Hong  Kong/1073/1999(H9N2),  by  age,
among  study  participants,  Kampong  Cham  province,
Cambodia,  2008.
Age  group  (years)  Total
20—39  40—59  ≥60
Titer
<1:10  428  277  51  756
1:10  0  9  5  14
1:20  2  4  0  6
1:160 0  1  0  1
(
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ATotal  430  291  56  777
90%)  were  positive  by  MN.  The  two  assays  showed
oderate agreement  (Kappa  coefﬁcient  =  0.41  (95%
I 0.27—0.55).  Considering  the  two  assays  as  ordi-
al measures,  the  magnitude  of  the  Spearman  rank
Table  4  Distribution  of  elevated  serologic  titers  by
age-group  against  A/Hong  Kong/1073/1999(H9N2),
A/Japan/305/1957(H2N2),  A/Env/Hong  Kong/
MP43156/2005(H2N2)  in  an  age-group  matched  subset
of  participants,  Kampong  Cham  province,  Cambodia,
2008.
Titer  Age  group  (years)  Total
20—39  40—59  ≥60
MN  titer  against  A/Hong  Kong/1073/1999(H9N2)
<1:10 3 20 5  28
1:10 0 7 3 10
1:20 1 2 0  3
1:40 0 0 0 0
1:80 0 0 0 0
1:160  0  1  0  1
Total  4  30  8  42
MN  titer  against  A/Japan/305/1957(H2N2)
<1:10  4  17  6  27
1:10  0  2  0  2
1:20  0  6  1  7
1:40  0  4  1  5
1:80  0  1  0  1
1:160  0  0  0  0
Total  4  30  8  42
MN  titer  against  avian-like  A/Env/Hong  Kong/
MP43156/2005(H2N2)
<1:10  3  10  2  15
1:10  0  3  2  5
1:20  0  3  2  5
1:40  0  11  1  12
1:80  0  2  1  3
1:160  0  1  0  1
Total  3  30  8  41
MN, microneutralization assay; HI, hemagglutination inhibi-
tion assay.
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orrelation  coefﬁcient  was  0.59,  suggesting  moder-
te correlation.
In addition  to  the  reactivity  against  the
vian H2N2  and  avian  H9N2  viruses,  one  sub-
ect had  an  elevated  MN  titer  (1:10)  against
/Duck/Memphis/546/74(H11N9),  and  a  second
ubject  had  an  elevated  MN  titer  (1:160)  against
/Duck/Alberta/60/76(H12N5),  but  these  sparse
ndings  were  not  further  explored.  Addition-
lly, 348  (48%)  of  the  800  Cambodian  partic-
pants had  antibody  titers  ≥1:40  against  the
/Swine/Minnesota/593/99(H3N2)  swine  inﬂuenza
irus (SIV),  while  none  had  an  elevated  titer
gainst A/Swine/Wisconsin/238/97(H1N1).  For  the
3N2 SIV,  age  group,  elevated  titer  against
/Panama/2007/99(H3N2)  titer,  and  smoking  were
igniﬁcant variables  with  bivariate  analysis.  Pig
xposure was  not  associated  with  an  elevated  titer,
uggesting  that  most  of  the  elevated  antibody  was
ue to  cross-reacting  antibody  against  human  H3
irus. Upon  multivariate  analysis,  only  age  group
nd elevated  antibodies  against  human  H3N2  were
igniﬁcant  risk  factors  for  H3N2  SIV  seropositivity.
en of  800  (1.25%)  sera  had  an  antibody  titer  ≥1:40
gainst A/Pandemic/Mexico/4108/2009(H1N1).
iscussion
pon  enrollment,  the  800  adult  rural  Cambodian
ohort members  reported  a  high  prevalence  of  pre-
ious poultry  and  swine  exposure  (Table  2).  While
3.6% of  cohort’s  sera  were  reactive  against  the
vian H2N2  virus,  >99%  of  the  seroreactive  mem-
ers were  born  before  1968,  suggesting  that  their
eactivity  was  likely  caused  by  antibodies  against
he H2N2  ‘‘Asian  ﬂu’’  pandemic  virus  that  emerged
n 1957  and  died  out  in  1968.
Nearly 3%  of  the  cohort  had  ele-
ated titers  against  the  avian-like  A/Hong
ong/1073/1999(H9N2)  inﬂuenza  virus,  although
xposure  to  poultry  was  not  signiﬁcantly  associated
ith  seropositivity  after  adjustment.  In  late  1997,
/quail/HK/G1/97(H9N2)  was  isolated  from  a
uail in  Hong  Kong;  this  virus  lineage  is  found  to
requently  circulate  among  domestic  poultry  in
he Asian  bird  markets  [19].  In  1999,  an  avian
9N2 inﬂuenza  virus  A/Hong  Kong/1073/1999
as isolated  from  a  young  girl  with  ILI  in  Hong
ong. This  virus  was  closely  related  to  the  quail
9N2 virus  [19,20].  Molecular  characterization
tudies indicated  that  these  H9  viruses  share  the
ix internal  genes  with  the  novel  HPAI  H5N1  virus
esponsible  for  18  human  infections  and  six  deaths
n Hong  Kong  in  1997  [21],  suggesting  that  H9N2
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viruses  contributed  to  the  emergence  of  the  HPAI
H5N1 viruses  causing  the  ‘‘bird  ﬂu’’  outbreak  in
Hong Kong  in  1997  through  genetic  reassortment.
A seroepidemiological  survey  of  150  sera  collected
from blood  donors  in  Hong  Kong  found  that  three
sera had  evidence  of  neutralizing  antibody  to
this avian-like  A/Hong  Kong/1073/1999(H9N2)
virus  [20].  Between  1998  and  1999,  10  addi-
tional human  H9N2  virus  infections  occurred
in China  [22],  and  since  the  early  2000s,  H9N2
subtype viruses  have  become  widespread  across
Asia [23].
In regards  to  host  range  and  receptor  speci-
ﬁcity, while  the  A/Hong  Kong/1997(H5N1)  HPAI
isolated  from  humans  retained  its  avian  virus-
like speciﬁcity  [24],  it  has  been  suggested  that
A/Hong  Kong/1073/1999(H9N2)  possesses  a unique
three-amino-acid  combination,  also  found  in  the
hemagglutinin  gene  of  human  H3  viruses,  that
gives it  a  human  inﬂuenza  virus-like  receptor
speciﬁcity, similar  to  that  of  human  H3N2  epi-
demic strains  [24].  In  addition,  evidence  of
interspecies  transmission  of  H9N2  AIVs  to  pigs
in China  and  their  co-circulation  with  human
H3N2 inﬂuenza  viruses  (A/Sydney/5/97-like  and
Sydney97-like  viruses)  in  pigs  was  reported,  high-
lighting the  opportunity  for  genetic  reassortment
[25]. The  capacity  of  the  H9  HA  surface  glycopro-
tein to  bind  both  avian  and  human  inﬂuenza  virus
receptors  and  its  capacity  to  infect  birds,  pigs,  and
humans highlight  the  pandemic  potential  of  these
H9N2 AI  viruses.
We can  only  hypothesize  as  to  the  implications
of our  ﬁnal  multivariate  model  showing  statis-
tically  signiﬁcant  reactivity  against  the  A/Hong
Kong/1073/1999(H9N2)  virus  that  was  not  asso-
ciated with  poultry  exposure.  Some  of  these
serological elevations  are  likely  due  to  cross-
reactivity; however,  evidence  for  cross-reactivity
due to  human  H2N2  was  not  present  in  the  sub-
study  mentioned  above.  It  seems  evident  from
the monoclonal  antibody  validation  work  that
some  seroreactivity  resulted  from  environmen-
tal exposures  not  captured  by  our  questionnaire.
A recent  report  by  Cheng  et  al.  documented
two human  avian  H9N2  infections  in  Hong  Kong,
and  the  authors  suggested  that  perhaps  such
H9N2 infections  are  more  common  than  previously
suspected [26].
The  inability  to  identify  a  speciﬁc  environmental
exposure is  not  unprecedented.  A  seroprevalence
study conducted  by  Cavailler  et  al.  in  August  2007
in Kampong  Cham  Province  identiﬁed  18  (2.6%)  of
700 subjects  that  were  seropositive  for  antibod-
ies against  a  Cambodian  HPAI  H5N1  virus,  yet  the
authors [27]  did  not  ﬁnd  poultry  exposure  or  any
I
a
v
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peciﬁc  sick-poultry  handling  practices  to  be  risk
actors for  seropositivity  for  HPAI  H5N1  virus.  A
006 Cambodian  environmental  survey  conducted
n Kampong  Cham  and  Prey  Veng  Provinces  detected
PAI  H5N1  virus  viral  RNA  in  27  (35%)  of  77  envi-
onmental samples  collected  from  soil,  mud,  pond
ater, and  pond  plants  [6],  thus  supporting  reports
uggesting  environmental  exposure  as  a  risk  factor
or seropositivity.
Regarding  age,  subjects  in  the  highest  age  cate-
ory (≥60  years  old)  were  signiﬁcantly  more  likely
o have  been  infected  with  the  avian-like  H9N2
irus,  which  suggests  that  older  adults  have  had
ore opportunities  for  exposure  to  the  virus  or  are
erforming  more  risky  behaviors  than  their  younger
ounterparts.  It  is  also  possible  that  younger  popu-
ations have  stronger  innate  immune  systems  that
re able  to  prevent  viral  infection  and  subsequent
roduction of  speciﬁc  antibodies.  This  population  is
ost likely  more  prominently  involved  with  raising
oultry  in  their  villages.
Our  laboratory  evidence  of  a high  preva-
ence (72%)  of  previous  exposure  to  the  human
/Brisbane/10/2007(H3N2)  virus  is  consistent  with
revious ﬁndings  by  Blair  et  al.,  who  identi-
ed H3N2  human  inﬂuenza  infections  through
assive surveillance  in  nine  Cambodian  hospitals
rom 2007  to  2008  that  were  closely  related  to
his same  strain  [11].  The  inverse  association
etween A/Brisbane/10/2007(H3N2)  seropositivity
nd A/Hong  Kong/1073/1999(H9N2)  seropositivity
ay reﬂect  immunologically  similar  N2  compo-
ents. As  discussed  above,  these  avian-like  H9N2
nﬂuenza  viruses  have  the  capacity  to  bind  both
vian   2—3  and  human   2—6  receptors  found
n the  human  upper  respiratory  tract.  Infection
ith A/Brisbane/10/2007(H3N2)  may  have  pro-
uced speciﬁc  antibodies  against  the  N2  that
ere  also  protective  against  subsequent  infec-
ion with  A/Hong  Kong/1073/1999(H9N2),  or  vice
ersa.
Nearly half  of  the  cohort  had  elevated  antibody
iters against  A/Swine/Minnesota/593/99(H3N2)
IV; however,  this  reactivity  most  likely  can  be
ttributed  to  cross-reactivity  with  a  human  H3N2
irus, as  A/Panama/2007/99(H3N2)  seropositivity
as highly  correlated  and  pig  exposure  was  not.
he identiﬁcation  of  10  subjects  bled  in  2008  with
eroreactivity  against  the  2009  pandemic  inﬂuenza
irus is  again  evidence  of  cross-reactivity  with  other
uman H1N1  inﬂuenza  strains.
This study  has  a  number  of  limitations.  Due  toRB concerns  and  study  execution  methods,  only
dults at  least  20  years  of  age  were  enrolled.  Pre-
ious studies  have  shown  that  younger  children
re at  risk  of  avian  inﬂuenza  virus  infections  [28]
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Iuman  avian  H9N2  inﬂuenza  infections  
r  HPAI  H5N1  virus  exposure  among  Cambodian
esidents [9];  thus,  a  large  subset  of  the  at-risk
opulation  may  have  been  excluded.  A  further
imitation may  be  the  speciﬁcity  of  the  serologi-
al assays.  The  aforementioned  serological  studies
y Stephensen  et  al.  [18]  and  Cavallier  et  al.
27] document  potential  confounding  from  cross-
eactivity  against  pandemic  H2N2  and  a  closely
elated  HPAI  virus,  A/Cambodia/408008/05(H5N1).
f the  viruses  used  to  examine  sera  reactivity  in  this
tudy were  antigenically  different  than  the  circu-
ating virus  strains  in  Cambodia,  then  the  negative
ssays  may  have  been  misleading.  It  is  also  possi-
le that  nonspeciﬁc  antibodies  might  explain  some
f the  subtle  MN  assay  elevations  we  detected.
n addition,  transportation  of  specimens  from  the
illages to  the  NAMRU2-NIPH  laboratory  and  to
he laboratories  in  the  United  States  was  thought-
ully planned  and  carefully  executed;  however,
actors outside  the  control  of  study  staff  may  have
ed to  the  degradation  of  serum  samples  during
ransport.
onclusions
lthough  the  role  of  cross-reactive  antibodies
rom human  seasonal  inﬂuenza  viruses  cannot
e completely  excluded,  our  study  data  suggest
hat a  number  of  participants  may  have  been
reviously infected  with  the  avian-like  A/Hong
ong/1073/1999(H9N2)  virus,  likely  due  to  as  yet
nidentiﬁed  environmental  exposures.  This  high-
ights the  need  for  further  work  to  elucidate  the
revalence  of  H9N2  inﬂuenza  virus  infections  in
umans.
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